Antibacterial peptides for therapeutic use: obstacles and realistic outlook.
about
Marine Antimicrobial Peptides: Nature Provides Templates for the Design of Novel Compounds against Pathogenic BacteriaDesign and Application of Antimicrobial Peptide ConjugatesAntimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal IndustryNanotechnology Formulations for Antibacterial Free Fatty Acids and MonoglyceridesThe Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical DiseasesOn the role of NMR spectroscopy for characterization of antimicrobial peptidesInsights into the antimicrobial properties of hepcidins: advantages and drawbacks as potential therapeutic agentsAntimicrobial peptides for therapeutic applications: a reviewPeptidomimetics as a new generation of antimicrobial agents: current progressCurrent and potential applications of host-defense peptides and proteins in urologyAedesin: Structure and Antimicrobial Activity against Multidrug Resistant Bacterial StrainsDermatophytic defensin with antiinfective potentialAntimicrobial Peptides Targeting Gram-Positive BacteriaA Cationic Amphiphilic Random Copolymer with pH-Responsive Activity against Methicillin-Resistant Staphylococcus aureusHighly selective end-tagged antimicrobial peptides derived from PRELPAn antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosisPeptidomimetic Star Polymers for Targeting Biological Ion ChannelsElucidation of the Mode of Action of a New Antibacterial Compound Active against Staphylococcus aureus and Pseudomonas aeruginosaLongipin: An Amyloid Antimicrobial Peptide from the Harvestman Acutisoma longipes (Arachnida: Opiliones) with Preferential Affinity for Anionic VesiclesEvaluation of the use of therapeutic peptides for cancer treatmentPredicting antimicrobial peptides with improved accuracy by incorporating the compositional, physico-chemical and structural features into Chou's general PseAAC.Antimicrobial peptide cWFW kills by combining lipid phase separation with autolysis.DRAMP: a comprehensive data repository of antimicrobial peptides.Antimycobacterial activity of Pichia pastoris-derived mature bovine neutrophil β-defensins 5.Novel synthetic antimicrobial peptides against Streptococcus mutans.End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing.Peptides, Peptidomimetics, and Polypeptides from Marine Sources: A Wealth of Natural Sources for Pharmaceutical Applications.The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infection.Novel technologies for the prevention and treatment of dental caries: a patent survey.D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung InfectionAntimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin woundsCationic methacrylate polymers as topical antimicrobial agents against Staphylococcus aureus nasal colonizationBiochemical characterization and evaluation of cytotoxicity of antistaphylococcal chimeric protein P128.Antimicrobial peptides targeting Gram-negative pathogens, produced and delivered by lactic acid bacteria.Role of cationic group structure in membrane binding and disruption by amphiphilic copolymersAzurophil granule proteins constitute the major mycobactericidal proteins in human neutrophils and enhance the killing of mycobacteria in macrophages.Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria.A new strategy to produce a defensin: stable production of mutated NP-1 in nitrate reductase-deficient Chlorella ellipsoidea.Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.Underlying mechanism of in vivo and in vitro activity of C-terminal-amidated thanatin against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli
P2860
Q26746943-B7D82D69-C774-46CC-9F99-D75BD701D627Q26749068-EA845A53-D7C7-4247-8E7C-62B68CB51F96Q26751499-CA403E33-AC47-48D8-A792-80A69FA3A6BFQ26767394-8A15D3B6-2BA5-4333-9B99-47E8F58E102AQ26797488-4C56AF00-FA96-4233-9EBF-8DF0517F462BQ26830116-EBDF18F4-7E98-4851-BB26-C3BFDB5B0C08Q26991996-B1F50240-20F6-410C-910E-4194CF30B149Q27004635-F8B69ACA-CF3E-454D-AA53-0019329EBE5DQ27026959-4ACEE68E-AE5F-4F73-B229-CE14651AC68AQ27027719-459D035A-3B94-47BA-89D4-1766ABB115A5Q27640548-B7DD3D46-F5BD-4671-9AFF-849B80A4E4C1Q27679095-3931AE3B-5083-4A06-864E-26FE6AE4F5E5Q28077888-7A8A3187-6B36-4A5C-971D-426986653990Q28468450-0CC4C954-F316-429A-9545-F6ACEE0F23C5Q28476835-2C6E6230-CA62-4010-9AC2-63EA9C54B426Q28534020-2C468BDC-9D9D-4461-A2D8-1A55978B6903Q28550966-99C5C3BF-80A0-4D83-AAC8-BD227841EBAFQ28551971-E078534A-1310-4733-8CB7-0375AFE2A925Q28555126-D535A6C2-21D7-4DAF-9463-8F785094128FQ29048586-2A12B3ED-B77E-495B-9E0E-DB424696F147Q30838333-8A1D963A-5D55-48F3-A332-2CCAD93B6C5EQ30841307-DDC7C1A0-090C-4D55-9DAC-43DC3C34ED2DQ31076607-B46CD4FA-11E3-49FA-8E0F-A4BBE643AD17Q31161382-746380DF-0168-4292-8EAB-8FB32F758165Q33273497-1AA34C21-27C3-460E-9C75-C5DB2C8EAF95Q33432726-FBE36570-B87A-46B8-8FE4-6DD960903038Q33612302-E74A18E7-273B-4A3B-9BF2-75DDD8E8C707Q33614145-B24C2430-DEBC-4D97-B08F-6AF2ECD70F22Q33802090-1EF415BD-9157-4D1E-BF83-2BD4EECC6A14Q33809988-00565911-5F6F-405E-8157-B0BD7879DAB6Q33869297-8C0BB2D5-2AB4-4D95-9FE3-D5C4415F4346Q34033741-C0E3F44C-63A3-4375-9C5D-1FFFFF523708Q34298267-FA82BD15-5071-4C3A-99BF-38791E7BC804Q34461789-68C208D0-3C2A-419C-B605-C4E67C8F3C4AQ34490949-BA7E81E8-7721-41AA-8E3C-81FF5A44BE0DQ34515757-E69D8D32-53D3-4F9B-8DA7-BA6E544BAB35Q34549813-7EF72822-67EE-4BDA-8836-17198CE3AFE1Q34575871-F65CDF41-5E7F-44D8-9355-69CB98334F9DQ34616362-BC0A1836-2922-4F74-9040-A883C7600188Q34763500-DF693765-81CC-485F-B854-6BD73DF19147
P2860
Antibacterial peptides for therapeutic use: obstacles and realistic outlook.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Antibacterial peptides for therapeutic use: obstacles and realistic outlook.
@ast
Antibacterial peptides for therapeutic use: obstacles and realistic outlook.
@en
type
label
Antibacterial peptides for therapeutic use: obstacles and realistic outlook.
@ast
Antibacterial peptides for therapeutic use: obstacles and realistic outlook.
@en
prefLabel
Antibacterial peptides for therapeutic use: obstacles and realistic outlook.
@ast
Antibacterial peptides for therapeutic use: obstacles and realistic outlook.
@en
P2093
P1476
Antibacterial peptides for therapeutic use: obstacles and realistic outlook.
@en
P2093
Alexandra K Marr
Robert Ew Hancock
William J Gooderham
P304
P356
10.1016/J.COPH.2006.04.006
P577
2006-08-04T00:00:00Z